Reduction in coronary heart disease with atorvastatin independent of low-density lipoprotein cholesterol

被引：2
|
作者：
Takagi, Hisato [1 ]
Umemoto, Takuya [1 ]
机构：
[1] Shizuoka Med Ctr, Dept Cardiovasc Surg, Shizuoka 4118611, Japan
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2011年 / 149卷 / 02期
关键词：
Atorvastatin; Coronary heart disease; Low-density lipoprotein cholesterol; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; DIABETES-MELLITUS; PRAVASTATIN; EFFICACY; OUTCOMES; CARE;
D O I：
10.1016/j.ijcard.2011.02.055
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
下载
收藏
页码：267 / 269
页数：4
相关论文
共 50 条
  • [21] What is the target for low-density lipoprotein cholesterol in patients with heart disease?
    Stevermer, JJ
    Meadows, SE
    JOURNAL OF FAMILY PRACTICE, 2002, 51 (10): : 893 - 893
  • [22] CHARACTERIZATION OF HIGH-DENSITY AND LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS IN PATIENTS WITH CORONARY HEART DISEASE IN GEORGIA
    Chachava, T.
    Trapaidze, D.
    Sturua, L.
    Geleishvili, M.
    Rush, T.
    Maes, E.
    JOURNAL OF HYPERTENSION, 2015, 33 : E275 - E275
  • [23] Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study
    Deedwania, Prakash
    Barter, Philip
    Carmena, Rafael
    Fruchart, Jean-Charles
    Grundy, Scott M.
    Haffner, Steven
    Kastelein, John J. P.
    LaRosa, John C.
    Schachner, Holly
    Shepherd, James
    Waters, David D.
    LANCET, 2006, 368 (9539): : 919 - 928
  • [24] An alternative marker of low-density lipoprotein cholesterol in coronary artery disease: non-high-density lipoprotein cholesterol
    Ercan, Mujgan
    Oguz, Esra
    Yilmaz, Fatma Meric
    Bogdaycioglu, Nihal
    Unal, Kubranur
    Sahin, Deniz
    Uysal, Sema
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2015, 45 (01) : 153 - 158
  • [25] Discordance of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol with Severity of Coronary Artery Disease
    Castro, Iran
    Fontana Filho, Hugo
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2020, 114 (03) : 476 - 476
  • [26] REDUCTION IN LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND CORONARY HEART-DISEASE EVENTS IN THE DIET PLUS PLACEBO GROUP IN THE CORONARY PRIMARY PREVENTION TRIAL
    GLUECK, CJ
    ARTERIOSCLEROSIS, 1984, 4 (05): : A543 - A543
  • [27] Combination therapy for elevated low-density lipoprotein cholesterol: The key to coronary artery disease risk reduction
    McKenney, J
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (10B): : 8K - 20K
  • [28] Low-Density Lipoprotein Cholesterol Targets in Patients With Coronary Heart Disease in Extremadura (Spain): LYNX Registry
    Javier Gomez-Barrado, Jose
    Gomez-Turegano, Paula
    Ortiz-Cortes, Carolina
    Vega-Fernandez, Jorge
    Gomez-Turegano, Marta
    Garciperez de Vargas, Francisco Javier
    Lezcano Gort, Luis Enrique
    Kounka, Zineb
    Roque Rodriguez, Benjamin
    Chipayo Gonzales, David
    Perez-Espejo, Paloma
    Isabel Fernandez-Chamorro, Ana
    Beltran Moreno, Maria
    Romero Castro, Maria Jose
    Mogollon Jimenez, Maria Victoria
    Marcos Gomez, Gonzalo
    Porras Ramos, Yolanda
    CARDIOLOGY RESEARCH, 2020, 11 (05) : 311 - 318
  • [29] Low-density lipoprotein cholesterol in patients with stable coronary heart disease - Is it time to shift our goals?
    Pitt, B
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (14): : 1483 - 1484
  • [30] APO-B AND CHOLESTEROL LEVELS IN LOW-DENSITY LIPOPROTEIN OF PATIENTS WITH CORONARY HEART-DISEASE
    VEGA, GL
    GRUNDY, SM
    ARTERIOSCLEROSIS, 1982, 2 (05): : A425 - A426
12345